Effect of high retinoid doses on RAR-β mRNA expression in female B6D2F1 mice

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1691-1695

  Johanning, G L ^a   Cope, M B ^a   Wilborn, T ^a   Grubbs, C J ^a   Lubet, R A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

13 cis retinoic acid; 4 hydroxyphenylretinamide; Mice; RAR expression; Retinoid receptors; Retinoids

Indexed keywords

FENRETINIDE; ISOTRETINOIN; MESSENGER RNA; RETINOIC ACID RECEPTOR; RETINOID;

ANIMAL TISSUE; ARTICLE; BLADDER; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; VITAMIN INTAKE;

ANIMALS; ANTICARCINOGENIC AGENTS; BLOTTING, NORTHERN; DNA, COMPLEMENTARY; FEMALE; FENRETINIDE; ISOTRETINOIN; LIVER; LUNG; MICE; RECEPTORS, RETINOIC ACID; RNA; RNA, MESSENGER; TISSUE DISTRIBUTION; URINARY BLADDER;

EID: 0034909548     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis
2. Elevated retinoic acid receptor beta protein in human breast tumor cells with nuclear and cytoplasmic localization
3. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization
4. Decreased expression of retinoic acid receptors, transforming growth factor beta, involucrin, and cornifin in cervical intraepithelial neoplasia
5. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer
6. Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignancies
7. Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: Immunohistochemical and western blot study
8. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor
9. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis
10. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
11. Elevated expression of retinoic acid receptor-alpha (RAR alpha) in estrogen-receptor-positive breast carcinomas as detected by immunohistochemistry
12. Expression of retinoic acid receptor proteins in basal cell carcinomas: An immunohistochemical analysis
13. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues
14. Retinoids and cancer prevention
15. Retinoic acid affects the expression of nuclear retinoic acid receptors in tissues of retinol-deficient rats
16. Differential effects of all-trans and 13-cis-retinoic acid on mRNA levels of nuclear retinoic acid receptors in rat lung and liver
17. Effect of retinoid status on alpha, beta and gamma retinoic acid receptor mRNA levels in various rat tissues
18. Chronic vitamin A intake affects the expression of mRNA for apolipoprotein A-I, but not for nuclear retinoid receptors, in liver of young and aging Lewis rats
19. Expression of retinoic acid nuclear receptors and tissue transglutaminase is altered in various tissues of rats fed a vitamin A-deficient diet
20. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention
21. Anhydroretinol, a retinoid active in preventing mammary cancer induced in rats by N-methyl-N-nitrosourea
22. 13-cis-retinoic acid: Inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine
23. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine
24. Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse
25. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
26. 13-cis-retinoic acid in the treatment of oral leukoplakia
27. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors
28. Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids
29. Subacute toxicity of all-trans- and 13-cis-isomers of N-ethyl retinamide, N-2-hydroxyethyl retinamide, and N-4-hydroxyphenyl retinamide
30. High frequency of retinoic acid receptor beta abnormalities in human lung cancer
31. Implication of RARβ in epidermoid (squamous) lung cancer
32. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells
33. Human lung cancer cell lines exhibit resistance to retinoic acid treatment
34. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: Implications for lung cancer development
35. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function
36. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells
37. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines
38. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin
39. Inappropriate retinoic acid receptor-beta expression in oral dysplasias: Correlation with acquisition of the immortal phenotype
40. N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat